Title:
MACROCYCLIC PEPTIDE ACTIVE AGAINST THE HEPATITIS C VIRUS
Document Type and Number:
Japanese Patent JP2011006420
Kind Code:
A
Abstract:
To provide an NS3 protease-inhibitive new compound.
There are provided a new peptide analog which is a macrocyclic compound advantageous as an HCV (hepatitis C virus) NS3 protease inhibitor, a pharmaceutical composition containing such an analog and a method of using such an analog in the treatment of HCV infection. The compound specifically inhibits NS3 protease and exhibits no significant suppressing activity against other serine proteases.
More Like This:
Inventors:
LLINAS-BRUNET MONTSE
BAILEY MURRAY
BHARDWAJ PUNIT
FORGIONE PASQUALE
GHIRO ELISE
GOUDREAU NATHALIE
HALMOS TEDDY
RANCOURT JEAN
BAILEY MURRAY
BHARDWAJ PUNIT
FORGIONE PASQUALE
GHIRO ELISE
GOUDREAU NATHALIE
HALMOS TEDDY
RANCOURT JEAN
Application Number:
JP2010156015A
Publication Date:
January 13, 2011
Filing Date:
July 08, 2010
Export Citation:
Assignee:
BOEHRINGER INGELHEIM INT
International Classes:
C07K5/00; A61K38/00; A61K38/06; A61K38/12; A61P31/12; A61P31/14; A61P43/00; C07K5/08; C07K5/087; C07K5/12; C07K11/00; C12N9/99
Domestic Patent References:
JP2002542160A | 2002-12-10 | |||
JP4398424B2 | 2010-01-13 | |||
JP4704342B2 | 2011-06-15 |
Foreign References:
WO2003053349A2 | 2003-07-03 | |||
WO2003064455A2 | 2003-08-07 | |||
WO2003066103A1 | 2003-08-14 |
Other References:
JPN6008051862; Angew.Chem.Int.Ed.Engl.,Vol.42,No.12(2003.Mar.)p.1356-1360
Attorney, Agent or Firm:
Sadao Kumakura
Nobuo Ogawa
Atsushi Hakoda
Kenji Asai
Nobuo Ogawa
Atsushi Hakoda
Kenji Asai
Previous Patent: LONG ACTING BIOLOGICALLY ACTIVE CONJUGATE
Next Patent: HALOGENATED RHODAMINE DERIVATIVE AND APPLICATION THEREOF
Next Patent: HALOGENATED RHODAMINE DERIVATIVE AND APPLICATION THEREOF